Scientists co-leading an international study, including researchers from UCLA, have demonstrated that a new targeted therapy drug called vorasidenib can prolong the duration of treatment without cancer progression in individuals ...
Copyright © 2013-24 MediaBites, Designed & Developed By Global Biz International.
Copyright © 2013-24 MediaBites, Designed & Developed By Global Biz International.